HEPATIC INJURY
See full prescribing information for complete boxed warning.
- TRADE NAMES: Drogenil; Euflex; Eulexin; Eulexine; Flucinom; Fluken; Flulem; Fugerel; Novo-Flutamide
- INDICATIONS: Metastatic prostate carcinoma
- CLASS: Androgen antagonist
- HALF-LIFE: 8–10 hours
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
None known - PREGNANCY: not indicated for use in women
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Click on the DRUG REVIEW ARTICLE tab (above) to see a review of flutamide in the Taylor & Francis journal Expert Opinion on Drug Safety.
(Note that non-subscribers to the journal will only be able to see an abstract of the article.)
Page last updated 10/06/2023
